ReviewMarine drugs2023
Application of Nanomaterials in the Production of Biomolecules in Microalgae: A Review.
Review in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 25 citations in OpenAlex.
- Integrated Algal Bioenergy Platforms: Advances in Microbial Fuel Cell Integration and Nanotechnology-Enabled Biorefineries.Nanomaterials (Basel, Switzerland) · 2026Review
- Abiotic stress effects on polyunsaturated fatty acid biosynthesis in Chlorococcum oleofaciens and Leptolyngbya sp.Applied microbiology and biotechnology · 2026Article
- Photosynthetic Microorganisms and Biogenic Synthesis of Nanomaterials for Sustainable Agriculture.Nanomaterials (Basel, Switzerland) · 2025Review
- Stage-Specific Effects of TiOMarine drugs · 2025Article
- Interactions Between Potentially Toxic Nanoparticles (Cu, CuO, ZnO, and TiONanomaterials (Basel, Switzerland) · 2024Article
- Traditional and new trend strategies to enhance pigment contents in microalgae.World journal of microbiology & biotechnology · 2024Review
- Effects of Silver Nanoparticles on the Red MicroalgaMarine drugs · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
Nanomaterials (NMs) are becoming more commonly used in microalgal biotechnology to empower the production of algal biomass and valuable metabolites, such as lipids, proteins, and exopolysaccharides. It provides an effective and promising supplement to the existing algal biotechnology. In this review, the potential for NMs to enhance microalgal growth by improving photosynthetic utilization efficiency and removing reactive oxygen species is first summarized. Then, their positive roles in accumulation, bioactivity modification, and extraction of valuable microalgal metabolites are presented. After the application of NMs in microalgae cultivation, the extracted metabolites, particularly exopolysaccharides, contain trace amounts of NM residues, and thus, the impact of these residues on the functional properties of the metabolites is also evaluated. Finally, the methods for removing NM residues from the extracted metabolites are summarized. This review provides insights into the application of nanotechnology for sustainable production of valuable metabolites in microalgae and will contribute useful information for ongoing and future practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.